Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Beijing Key Laboratory of Emerging Infectious Diseases, The National Clinical Key Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Aging Cell. 2018 Apr;17(2). doi: 10.1111/acel.12716. Epub 2018 Jan 19.
Aging is associated with immune dysfunction, especially T-cell defects, which result in increased susceptibility to various diseases. Previous studies showed that T cells from aged mice express multiple inhibitory receptors, providing evidence of the relationship between T-cell exhaustion and T-cell senescence. In this study, we showed that T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (ITIM) domain (TIGIT), a novel co-inhibitory receptor, was upregulated in CD8 T cells of elderly adults. Aged TIGIT CD8 T cells expressed high levels of other inhibitory receptors including PD-1 and exhibited features of exhaustion such as downregulation of the key costimulatory receptor CD28, representative intrinsic transcriptional regulation, low production of cytokines, and high susceptibility to apoptosis. Importantly, their functional defects associated with aging were reversed by TIGIT knockdown. CD226 downregulation on aged TIGIT CD8 T cells is likely involved in TIGIT-mediated negative immune suppression. Collectively, our findings indicated that TIGIT acts as a critical immune regulator during aging, providing a strong rationale for targeting TIGIT to improve dysfunction related to immune system aging.
衰老是与免疫功能障碍相关的,尤其是 T 细胞缺陷,这会导致对各种疾病的易感性增加。先前的研究表明,来自老年小鼠的 T 细胞表达多种抑制性受体,为 T 细胞耗竭与 T 细胞衰老之间的关系提供了证据。在这项研究中,我们表明,T 细胞免疫球蛋白和免疫受体酪氨酸抑制基序(ITIM)结构域(TIGIT),一种新的共抑制受体,在老年人的 CD8 T 细胞中上调。衰老的 TIGIT+CD8 T 细胞表达高水平的其他抑制性受体,包括 PD-1,并表现出衰竭的特征,如关键共刺激受体 CD28 的下调、代表性的内在转录调节、细胞因子产生减少和凋亡易感性增加。重要的是,TIGIT 敲低逆转了与衰老相关的功能缺陷。衰老的 TIGIT+CD8 T 细胞上 CD226 的下调可能涉及 TIGIT 介导的负免疫抑制。总之,我们的研究结果表明,TIGIT 在衰老过程中充当关键的免疫调节剂,为靶向 TIGIT 以改善与免疫系统衰老相关的功能障碍提供了强有力的依据。